The company operates an equity based share option scheme to certain employees which provides additional remuneration for those who are key to the company. The options are granted under an approved EMI scheme, with the exercise price of £0.0001. The options expire five years after the date of the grant. Option holders are not entitled to dividends until the shares are exercised. All EMI options granted have performance conditions relating to the relevant employee remaining in the employment of the company at exercise.
A reconciliation of share option movements during the year ended 31 March 2026 is shown below:
Number of options - Weighted average exercise price
Outstanding as at 1 April 2025: Nil - £Nil (2025: Nil - £Nil)
Granted during the year: 602,100 - £0.0001 (2025: Nil - £Nil)
Forfeited during the year: Nil - £Nil (2025: Nil - £Nil)
Exercised during the year: Nil - £Nil (2025: Nil - £Nil)
Outstanding as at 31 March 2026: 602,100 - £0.0001 (2025: Nil - £Nil)
Equity settled schemes - charges arising: £144,454 (2025: £Nil)